Los Angeles Cancer Network ( Site 0025) — Glendale, California

Public research footprint of Los Angeles Cancer Network ( Site 0025), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Non Small Cell Lung Cancer (Squamous or Non Squamous) · Colorectal Neoplasms · Carcinoma, Non-Small-Cell Lung

Recently updated registry entries

NCT07365319 — A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy… (Recruiting)
NCT07623161 — A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are… (Recruiting)
NCT06667076 — A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Los Angeles Cancer Network ( Site 0025)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.